Table 3.

Factors associated with overall survival among cervical cancer patients (N=190) (Kaplan-Meier survival analysis).

Predictor	Survival time (months)			P value
	Mean	95%CI
FIGO stage
I	120.2	97.6	142.8	<.001
II	110.9	91.0	130.8
III	37.8	26.3	49.2
IV	33.9	16.2	51.6
Grade
I	129.3	107.3	151.2	.001
II	88.1	68.7	107.5
III	82.9	58.1	107.7
Parametrium
No	109.3	88.2	130.5	.020
Yes	88.4	72.5	104.3
Right pelvis
No	109.6	92.7	126.6	<.001
Yes	46.7	27.3	66.1
Left pelvis
No	105.8	89.4	122.2	<.001
Yes	50.2	27.3	73.2
Bladder
No	103.9	87.8	120.1	.001
Yes	46.2	29.3	63.1
Rectum
No	101.7	86.1	117.2	.001
Yes	31.8	15.9	47.7
Vagina
No	96.4	81.4	111.4	.036
Yes	88.2	68.5	108.0
No local involvements
0	116.9	95.6	138.2	<.001
1-3	97.1	78.7	115.4
4+	57.4	36.2	78.7
Distal metastasis
No	108.9	92.4	125.4	<.001
Yes	33.4	17.7	49.2
Hydronephrosis
No	109.6	92.9	126.4	<.001
Yes	31.5	20.5	42.6
Cut-through hysterectomy
No	98.5	83.5	113.6	.021
Yes	19.0	16.7	21.2
Radical hysterectomy
No	90.3	73.6	106.9	.007
Initial	107.2	86.4	127.9
After RT/CT	30.5	11.3	49.7
Radiotherapy
No	87.8	62.6	112.9	.889
Initial	93.9	76.5	111.5
Adjuvant	89.4	65.1	113.8
Chemotherapy
No	77.9	57.9	97.9	.272
Concurrent	102.2	81.7	122.6
Adjuvant	85.9	60.3	111.6
Systemic CT
No	97.9	82.8	113.2	.469
Yes	47.9	24.2	71.5
Palliative care
No	101.8	86.4	117.2	<.001
Yes	12.1	1.8	22.5
Recurrence
No	118.1	98.1	138.1	<.001
Yes	56.8	40.4	73.1

Log rank test. Time variable=time from diagnosis to last follow up, event=death. CI: Confidence interval.